![](/img/cover-not-exists.png)
477 Capecitabine dose modification minimises side effects without compromising efficacy in pretreated metastatic breast cancer (MBC)
R. Leonard, B.T. Hennessy, J.L. Blum, J. O'ShaughnessyVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70498-5
File:
PDF, 49 KB
english, 2010